Symicort - Management Medication for Asthma and COPD
Symicort FAQ
What is Symbicort used for?
Symbicort is used to control and prevent the symptoms of asthma in adults and children at least 6 years old. Symbicort is also used to help control the symptoms of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. Symbicort is not for use in treating an asthma or bronchospasm attack.
How effective is Symbicort?
In the two 12-week, double-blind, placebo-controlled US pivotal studies 25 patients 12 to 17 years of age were treated with SYMBICORT twice daily [see Clinical Studies (14.1)]. Efficacy results in this age group were similar to those observed in patients 18 years and older.
Is Symbicort a brand?
SYMBICORT is a trademark of the AstraZeneca group of companies. FORADIL AEROLIZER is a trademark of Novartis Pharmaceuticals Corporation. How long can you be on Symbicort?
How long does Symbicort take to work?
Improvement in asthma control following inhaled administration of SYMBICORT can occur within 15 minutes of beginning treatment, although maximum benefit may not be achieved for 2 weeks or longer after beginning treatment. Individual patients will experience a variable time to onset and degree of symptom relief.
Symicort References
If you want to know more about Symicort, consider exploring links below:
What Is Symicort
- https://www.drugs.com/symbicort.html
- https://www.nhs.uk/medicines/budesonide-inhalers/about-budesonide-inhalers/
- https://www.medicalnewstoday.com/articles/symbicort
- https://patient-info.co.uk/symbicort-200-6-turbohaler-95899/patient-leaflet
Symicort Information
Explore Related Topics
The Evolution of AI in Asthma Management: From Concept to Clinic
Tracing the journey of AI technology from initial concept to practical application in clinical asthma management.